Ronald Vladyka
18Patents
7h-index
25Co-inventors
66Inventor score
Filing activity: Apr 17, 1996 → Dec 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5858409A | Hydrolyzed cellulose granulations for pharmaceuticals | Human Necessities | 51 | Expired |
| US5904937A | Taste masked pharmaceutical compositions | Human Necessities | 29 | Expired |
| US6379707B2 | Method of making granular pharmaceutical vehicle | Chemistry; Metallurgy | 26 | Expired |
| US6497905B1 | Aqueous solubility pharmaceutical formulations | Chemistry; Metallurgy | 13 | Expired |
| US6511681B2 | Aqueous solubility pharmaceutical formulations | Chemistry; Metallurgy | 13 | Expired |
| US7767225B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 8 | Active |
| US6858725B1 | Microcrystalline cellulose cushioning granules | Chemistry; Metallurgy | 7 | Expired |
| US7988994B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 5 | Active |
| US11660267B2 | Sublingual formulation of riluzole | Human Necessities | 4 | Active |
| US8383150B2 | Granulate formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 4 | Active |
| US11529313B2 | Twin-screw dry granulation for producing solid formulations | Performing Operations; Transporting | 2 | Active |
| US8753679B2 | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | Emerging Cross-Sectional Technologies | 2 | Active |
| US8496967B2 | Oral formulations | Human Necessities | 1 | Active |
| US10786459B2 | Twin-screw dry granulation for producing solid formulations | Performing Operations; Transporting | 1 | Active |
| US6596312B1 | Hydrolyzed cellulose granulations of salts of drugs | Human Necessities | 1 | Expired |
| US12178912B2 | Twin-screw dry granulation for producing solid formulations | Performing Operations; Transporting | 0 | Active |
| US12121609B2 | Sublingual formulation of riluzole | Human Necessities | 0 | Active |
| US11253501B2 | Secnidazole formulations and use in treating bacterial vaginosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.